Drug
Abbv 8e12
Abbv 8e12: highest development phase Phase 2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABBV-8E12 NCT02985879 | Phase 2 | Progressive Supranuclear Palsy |
Latest
No recent events.
Follow Abbv 8e12 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.